These documented adverse occasions transpired at an incidence of 1% or fewer. Nonetheless, available information can not give a responsible estimate from the incidence, if any, of dependence during treatment at recommended doses. Postmarketing experiences of abuse, dependence and withdrawal have already been received.This strain is observed for its